Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Hemodialysis International. International Symposium on Home Hemodialysis|March 30, 2010
Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patientsJong Chan Park, Csaba P Kovesdy, Uyen Duong, et al.Kidney International|March 21, 2014
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patientsJürgen Floege, Adrian C Covic, Markus Ketteler, et al.Archives of Oral Biology|June 9, 2017
Differential expression between "DSP-only" and DSP-PP523 transcripts in rat molar teethYa-Qin Zhu, Ryan M Song, Helena H RitchieJournal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 5, 2010
Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patientsRamanath Dukkipati, Csaba P Kovesdy, Sara Colman, et al.American Journal of Nephrology|February 23, 2025
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized TrialAkhtar Ashfaq, John Choe, Stephen A Strugnell, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4Jack W Coburn, Hla M Maung, Logan Elangovan, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 22, 2009
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HClStuart M Sprague, Pieter Evenepoel, Mario P Curzi, et al.Journal of Clinical Medicine|April 12, 2022
Radiomics-Based Image Phenotyping of Kidney Apparent Diffusion Coefficient Maps: Preliminary Feasibility & EfficacyLu-Ping Li, Alexander S Leidner, Emily Wilt, et al.American Journal of Nephrology|October 5, 2007
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysisEdward A Ross, Jin Tian, Hanna Abboud, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKDDaniel Coyne, Muralidhar Acharya, Ping Qiu, et al.Pageof 10